Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

IRIDEX Corp (NASDAQ:IRIX)

12.25
Delayed Data
As of 3:59pm ET
 -0.04 / -0.33%
Today’s Change
9.87
Today|||52-Week Range
16.64
-12.87%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$141.6M

Company Description

IRIDEX Corp. engages in the development, manufacture, and market of therapeutic based laser consoles, delivery devices, and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. It sells lasers, laser delivery and glaucoma devices; retina surgical instruments; veterinary, and ear, nose, and throat products. It operates through the following geographical segments: United State, Europe, Rest of Americas, and Asia/Pacific Rim. The company was founded by Eduardo Arias, Theodore A. Boutacoff, and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Contact Information

IRIDEX Corp.
1212 Terra Bella Avenue
Mountain View California 94043
P:(650) 940-4700
Investor Relations:

Employees

Shareholders

Other institutional55.65%
Individual stakeholders42.18%
Mutual fund holders10.52%

Top Executives

William M. MooreChairman, President & Chief Executive Officer
Atabak MokariChief Financial Officer & VP-Corporate Development
Steven ChristensenVice President-Engineering
Paul H. HardimanVice President-Regulatory & Compliance
Timothy D. BuckleyVice President-Marketing & North American Sales